A Study to Evaluate the Effectiveness of Essure Post-NovaSure Radiofrequency Endometrial Ablation Procedure Following a Successful Essure Confirmation Test
Public ClinicalTrials.gov record NCT01740687. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of the post approval study is to evaluate the effectiveness and safety of the Essure System when a NovaSure Endometrial Ablation procedure is performed following a successful Essure Confirmation Test.
Study identification
- NCT ID
- NCT01740687
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 211 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 21 Years to 50 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 13, 2012 (Actual)
- Primary completion
- May 17, 2021 (Actual)
- Completion
- Jun 14, 2021 (Actual)
- Last update posted
- Feb 6, 2023
2012 – 2021
United States locations
- U.S. sites
- 17
- U.S. states
- 15
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Aurora | Colorado | 80045 | — |
| Not listed | Ocala | Florida | 34471 | — |
| Not listed | Decatur | Illinois | 62526 | — |
| Not listed | Fort Wayne | Indiana | 46825 | — |
| Not listed | Newburgh | Indiana | 47630 | — |
| Not listed | Easton | Maryland | 21601 | — |
| Not listed | Grand Blanc | Michigan | 48439 | — |
| Not listed | Maplewood | Minnesota | 55109 | — |
| Not listed | Las Vegas | Nevada | 89102 | — |
| Not listed | Neptune City | New Jersey | 07753 | — |
| Not listed | Winston-Salem | North Carolina | 27103 | — |
| Not listed | Englewood | Ohio | 45322 | — |
| Not listed | Mason | Ohio | 45040 | — |
| Not listed | Pottstown | Pennsylvania | 19464 | — |
| Not listed | Nashville | Tennessee | 37232 | — |
| Not listed | Norfolk | Virginia | 23507 | — |
| Not listed | Spokane | Washington | 99204 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01740687, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 6, 2023 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01740687 live on ClinicalTrials.gov.